Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
暂无分享,去创建一个
F. Khuri | W. Hong | J. Soria | S. Jang | L. Mao | K. Hassan | D. Liu | L Mao | W K Hong | F R Khuri | J C Soria | S J Jang | D Liu | K Hassan | Diane Liu | Li Mao | W. Hong
[1] K. Ohshima,et al. Expressions of cyclin E, A, and B1 in Hodgkin and Reed–Sternberg cells: Not suppressed by cyclin‐dependent kinase inhibitor p21 expression , 1999, Pathology international.
[2] Z. Darżynkiewicz,et al. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. , 1994, Cancer research.
[3] J. Richie,et al. Expression of cell cycle-regulated proteins in prostate cancer. , 1996, Cancer research.
[4] M. Furihata,et al. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma , 1999, Virchows Archiv.
[5] J. Mate,et al. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. , 1993, Oncogene.
[6] C. Sherr. Cancer Cell Cycles , 1996, Science.
[7] Jennifer Kushner,et al. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[8] R. Dodge,et al. Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer. , 1993, Archives of surgery.
[9] F. Mertens,et al. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression , 1997, Cancer.
[10] H. Koizumi,et al. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses. , 1997, The American journal of pathology.
[11] G Bussolati,et al. Value of Ki-67 immunostaining in preoperative biopsies of carcinomas of the lung. , 1997, Human pathology.
[12] T. Sekiya,et al. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. , 1992, Cancer research.
[13] D. Mason,et al. Ki‐67 immunostaining and survival in operable lung cancer , 1991, Histopathology.
[14] Taylor Murray,et al. Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.
[15] P. Demoly,et al. Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers. , 1996, British Journal of Cancer.
[16] W F Taylor,et al. Survival of patients surgically treated for stage I lung cancer. , 1981, The Journal of thoracic and cardiovascular surgery.
[17] N. Nishida,et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. , 1994, Cancer research.
[18] B. Angus,et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. , 1995, Oncogene.
[19] S. Kim,et al. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. , 2000, Cancer research.
[20] R. Cherian,et al. Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma : relationship to cell death, proliferation, and transformation. , 2000, The American journal of pathology.
[21] N. Weidner,et al. Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer. , 1998, Lung cancer.
[22] K. Sasaki,et al. Intracellular localization of cyclin B1 during the cell cycle in glioma cells. , 1996, Cytometry.
[23] J. M. Lee,et al. p53 regulates a G2 checkpoint through cyclin B1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Scagliotti,et al. Prognostic significance of Ki67 labelling in resected non small cell lung cancer. , 1993, European journal of cancer.